Clinical Trial Update: Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth

View source ↗

Summary

The study evaluating amniochorionic membrane cells in maternal blood as a biomarker for preterm birth has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Preterm Labor
• Preterm Premature Rupture of Membranes

Snippet

Sponsor: University of Aarhus | Conditions: Preterm Birth, Preterm Premature Rupture of Membrane | Status: COMPLETED